Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer.

D Mazhar1, J Waxman

  • 1Department of Cancer Medicine, Faculty of Medicine, Imperial College of Science, Technology and Medicine, London, UK.

Postgraduate Medical Journal
|November 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extension of the intravitreal injection interval after switching to faricimab in patients with exudative AMD: The multicenter FAR WEST study.

Journal francais d'ophtalmologie·2026
Same author

Disruption of androgen receptor-cofactor interactions by the RNA-binding protein FUS/TLS alters androgen signalling in prostate cancer.

Oncogene·2026
Same author

[Autofluorescence in a case of retinal astrocytic hamartoma].

Journal francais d'ophtalmologie·2021
Same author

[Atypical inflammmatory presentation of an iris juvenile xanthogranuloma in a 10-month-old girl].

Journal francais d'ophtalmologie·2021
Same author

A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3).

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Circulating microRNAs as potential new biomarkers for prostate cancer.

British journal of cancer·2013

Early prostate cancer detection is common, but its survival benefit is unclear. This review covers prostate cancer

Area of Science:

  • Oncology
  • Urology

Background:

  • Early cancer detection improves survival, a key principle in cancer treatment.
  • Screening for prostate cancer increases detection rates.
  • The benefit of early detection and treatment for localized prostate cancer on overall mortality remains uncertain.

Purpose of the Study:

  • To review the natural history of prostate cancer.
  • To discuss current and evolving management strategies for prostate cancer.

Main Methods:

  • Literature review of prostate cancer natural history and management.
  • Analysis of treatment options including surveillance, radiotherapy, and radical prostatectomy.
  • Examination of hormonal therapy for advanced prostate cancer.

Main Results:

Related Experiment Videos

  • No definitive evidence base exists to evaluate the comparative benefits of surveillance, radiotherapy, or radical prostatectomy for localized prostate cancer.
  • Significant advancements in chemotherapy and radiation have occurred in the last two decades.
  • Hormonal therapy is the standard for advanced prostate cancer management.

Conclusions:

  • Further research is needed to establish evidence-based guidelines for localized prostate cancer treatment.
  • Recent treatment advancements offer more humane options for patients.
  • Understanding the natural history is crucial for effective prostate cancer management.